KIRSTEN MANGANIELLO: Open Payments
NPI 1104259050 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 45 payments from 17 companies in 2025. Trend: 2023 $449 · 2024 $762 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $225 |
| Novo Nordisk Inc | 6 | $108 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| ABBVIE INC. | 4 | $94 |
| SHIELD THERAPEUTICS INC | 4 | $81 |
| Amgen Inc. | 4 | $79 |
| Insulet Corporation | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Verona Pharma, Inc. | 1 | $27 |
Products named: AIRSUPRA, ACCRUFER, TRELEGY ELLIPTA, Omnipod, CAPLYTA, VRAYLAR, OTEZLA, BREZTRI.
Industry payments across NY — which companies pay providers there.
